Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
73.77
Dollar change
-0.47
Percentage change
-0.63
%
IndexS&P 500 P/E16.58 EPS (ttm)4.45 Insider Own1.07% Shs Outstand550.75M Perf Week-1.48%
Market Cap39.41B Forward P/E11.15 EPS next Y6.62 Insider Trans0.00% Shs Float528.52M Perf Month4.92%
Income2.44B PEG1.29 EPS next Q0.44 Inst Own92.49% Short Float / Ratio1.36% / 2.33 Perf Quarter11.07%
Sales150.10B P/S0.26 EPS this Y13.35% Inst Trans-1.29% Short Interest7.21M Perf Half Y6.91%
Book/sh47.32 P/B1.56 EPS next Y0.99% ROA2.95% Target Price82.89 Perf Year-15.55%
Cash/sh- P/C- EPS next 5Y12.82% ROE9.65% 52W Range60.83 - 87.79 Perf YTD-10.05%
Dividend- P/FCF7.23 EPS past 5Y-2.49% ROI5.54% 52W High-15.97% Beta0.41
Dividend %- Quick Ratio- Sales past 5Y25.08% Gross Margin- 52W Low21.27% ATR1.60
Employees74300 Current Ratio1.12 Sales Q/Q6.07% Oper. Margin2.69% RSI (14)54.47 Volatility1.78% 2.14%
OptionableYes Debt/Eq0.76 EPS Q/Q-31.83% Profit Margin1.63% Rel Volume0.87 Prev Close74.24
ShortableYes LT Debt/Eq0.74 EarningsOct 24 BMO Payout0.00% Avg Volume3.09M Price73.77
Recom2.17 SMA200.60% SMA503.35% SMA2009.02% Volume2,680,143 Change-0.63%
Date Action Analyst Rating Change Price Target Change
Sep-05-23Upgrade BofA Securities Underperform → Neutral $79 → $72
Aug-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $94 → $73
Jul-12-23Downgrade Wolfe Research Outperform → Peer Perform
Jun-20-23Initiated UBS Neutral $72
Apr-21-23Initiated Cantor Fitzgerald Overweight $80
Mar-08-23Downgrade Deutsche Bank Buy → Hold $94 → $79
Feb-23-23Downgrade JP Morgan Overweight → Neutral $94 → $90
Dec-13-22Downgrade BofA Securities Neutral → Underperform $100 → $85
Sep-30-22Initiated Argus Buy $90
Aug-26-22Downgrade Wells Fargo Overweight → Equal Weight $103 → $99
Dec-08-23 10:37AM
10:13AM
Dec-07-23 11:36AM
10:00AM
Dec-06-23 02:00PM
09:00AM Loading…
Dec-05-23 09:00AM
Dec-04-23 12:13PM
08:30AM
08:00AM
Dec-03-23 09:04PM
Dec-01-23 06:51PM
Nov-30-23 08:00AM
Nov-29-23 09:40AM
Nov-28-23 03:01PM
Nov-23-23 11:30AM
09:42AM Loading…
09:42AM
09:33AM
Nov-20-23 03:00PM
09:40AM
05:39AM
Nov-16-23 06:00PM
04:30PM
Nov-15-23 07:15AM
06:07AM
Nov-14-23 11:00AM
Nov-13-23 09:40AM
Nov-09-23 09:52PM
06:16PM
Nov-06-23 05:56AM
Nov-03-23 09:08AM
08:08AM Loading…
08:08AM
01:08AM
Nov-02-23 12:00PM
11:05AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
Nov-01-23 09:45AM
Oct-27-23 12:08PM
09:40AM
Oct-26-23 07:35AM
Oct-25-23 09:54AM
09:40AM
08:30AM
Oct-24-23 11:12PM
04:35PM
12:30PM
10:47AM
10:28AM
09:41AM
09:30AM
07:15AM
06:16AM
06:09AM
06:05AM
06:00AM
Oct-23-23 04:15PM
Oct-18-23 06:01AM
Oct-17-23 12:03PM
11:05AM
10:00AM
Oct-16-23 12:24PM
10:05AM
09:45AM
Oct-15-23 11:53PM
Oct-12-23 11:47AM
Oct-11-23 07:00AM
Oct-10-23 06:17AM
Oct-09-23 08:21AM
Oct-06-23 09:00AM
Oct-05-23 09:40AM
Oct-03-23 04:40PM
10:10AM
Oct-02-23 08:30AM
Sep-28-23 04:06PM
Sep-27-23 09:50AM
06:01AM
Sep-26-23 05:56PM
05:07PM
02:14PM
Sep-25-23 09:45AM
09:00AM
Sep-21-23 04:15PM
Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Robinson Lori JeanDirectorApr 27Sale66.591,40093,2268,508Apr 28 06:04 PM
LONDON SARAHChief Executive OfficerMar 17Buy62.6030,0001,878,000313,953Mar 17 03:55 PM
Asher Andrew LynnEVP, CFOFeb 10Buy71.973,800273,486314,755Feb 10 03:00 PM
Asher Andrew LynnEVP, CFOFeb 09Buy71.893,000215,670310,955Feb 10 03:00 PM
Samuels Theodore R. IIDirectorFeb 08Buy71.887,000503,16011,912Feb 09 05:07 PM
MURRAY JAMES EEVP, Chief Operating OfficerFeb 08Buy73.306,750494,775136,220Feb 09 05:07 PM